Armstrong, H.; Petrova, A.; Wilsdon, T.; Homoki, H.; Roediger, A.
Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay? J. Mark. Access Health Policy 2025, 13, 2.
https://doi.org/10.3390/jmahp13010002
AMA Style
Armstrong H, Petrova A, Wilsdon T, Homoki H, Roediger A.
Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay? Journal of Market Access & Health Policy. 2025; 13(1):2.
https://doi.org/10.3390/jmahp13010002
Chicago/Turabian Style
Armstrong, Hannah, Angelina Petrova, Tim Wilsdon, Henriette Homoki, and Alexander Roediger.
2025. "Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay?" Journal of Market Access & Health Policy 13, no. 1: 2.
https://doi.org/10.3390/jmahp13010002
APA Style
Armstrong, H., Petrova, A., Wilsdon, T., Homoki, H., & Roediger, A.
(2025). Multi-Year Multi-Indication Agreements for Supporting Patient Access to Oncology Medicines with Multiple Indications: An Experimental Approach or Here to Stay? Journal of Market Access & Health Policy, 13(1), 2.
https://doi.org/10.3390/jmahp13010002
